WebApr 7, 2024 · CTI BioPharma Corp’s trailing 12-month revenue is $53.9 million with a -172.4% profit margin. Year-over-year quarterly sales growth most recently was %. … WebApr 4, 2024 · The technique has proven to be very useful for finding positive surprises. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of ...
CTI BioPharma (CTIC) Price To Cash Flow - Zacks.com
WebMar 29, 2024 · Buy CTI Biopharma Corp NASDAQ:CTIC stock? Extensive information, signals, indicators to help you decide if to buy or sell your stock. ... CTI BioPharma Corp. (NASDAQ:CTIC ) Q3 2024 Results Earnings Conference Call November 8, 2024 4:30 PM ET Company Participants Adam Craig - President, Chief Executive Officer and Interim … WebCTI BioPharma (CTIC) Reports Q4 Loss, Lags Revenue Estimates. CTI BioPharma (CTIC) delivered earnings and revenue surprises of -55.56% and 15.24%, respectively, for the quarter ended December 2024 ... inconsistency\u0027s pt
CTIC - Cti Biopharm Corp Stock Price - Barchart.com
WebMar 28, 2024 · CTI BioPharma Corp. (CTIC) latest earnings report: revenue, EPS, surprise, history, news and analysis. WebStock Quote. Change Volume 52 Week High 52 Week Low Apr 13, 2024 1:41 PM EDT. Data Provided by Refinitiv. ... Wash. , April 12, 2024 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today … WebOn Mar 06, 2024, Cti Biopharma ( NASDAQ: CTIC) reported Q4 2024 earnings per share (EPS) of -$0.12, up 69.23% year over year. Total Cti Biopharma earnings for the quarter were -$17.46 million. In the same quarter last year, Cti Biopharma 's earnings per share (EPS) was -$0.39. If you're new to stock investing, here's how to buy Cti Biopharma stock. inconsistency\u0027s qc